Investing Profile

Michael Liang

InvestorVC
Venture Capital Investor in the Healthcare Sector at Baird Capital
Photo of Michael Liang, Venture Partner at Baird Capital
cb
Baird Capital Venture Partner
$100K - $5.0M
$1.5M
19
$310M
CompanyStageDateRound SizeTotal Raised
Alto Neuroscience
Series CNov 2023$45M
$130M
Co-investors: Stephen Hays (What If Ventures), Christian Angermayer (Presight Capital), Martin Alexander Gershon (Endeavor Venture Funds), Tim Kendall
Greenlight Biosciences
Series DJun 2020$100M
Series UnknownMay 2020$17M
Series UnknownJan 2019$50M
$170M
OncoHealth
Series CMay 2020$28M
$51M
Co-investors: Annie Lamont (Oak HC/FT), Eugene Zhang (TSVC Capital), David Wu (Maveron)
Zurex Pharma
Series DJun 2018$9M
Series BJul 2014$4M
Series AMay 2012$6M
$19M
Amphora Medical
Series BJul 2017$36M
$36M
Co-investors: Ketan Patel (F-Prime Capital Partners)
Veniti
Series CMar 2015$17M
Series BJun 2013$10M
Series AMar 2011$14M
$41M
Integrated Diagnostics
Series BApr 2014$32M
$78M
Co-investors: Doug Fisher (InterWest)
Insightra Medical
Series COct 2013